Skip to content
2000
Volume 6, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Background

Coronaviruses are the genetic series of RNA viruses that infect both organisms mammals and birds. Different varieties of illnesses shown in humans as well as in birds are the most common causes ranging from minor to fatal. Common colds which are included in mild and SARS, MERS, and COVID-19 are caused by fatal. After cell entry, the release of RNA into the cytoplasm occurs, which translates viral proteins followed by processed replication.

Objective

The survey was based on a comparison study between the purchase of OTC and prescribed drugs for COVID-19 symptoms, including the volume of pharmacies from different zones of Yamunanagar district, Haryana.

Methods

The analytical survey involves the different zones of Yamunanagar the pharmacist used in this report. The numerical data is gathered in a methodical investigation which leads to quantitative research. The data investigation was performed by using Statistical Package for Social Sciences (SPSS) version 20.

Results

The north zone area mostly suffered from the COVID-19 pandemic condition from January 2021 to June 2021 in Yamunanagar and found that most of the OTC drugs purchased by consumers were paracetamol (PCM) and Prescribed drugs (HQCS + Azithromycin) by the public regarding covid-19 symptoms.

Conclusion

The outcome of this case report reveals that no statistically significant difference exists between the population parameter and sample statistics while the comparison retained the null hypothesis in different zones of Yamunanagar (Haryana), India including the volume of pharmacy and drug category.

Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975282230240125113214
2024-02-01
2025-01-06
Loading full text...

Full text loading...

References

  1. GorbalenyaA.E. BakerS.C. BaricR.S. The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2.Nat. Microbiol.20205453654410.1038/s41564‑020‑0695‑z 32123347
    [Google Scholar]
  2. GorbalenyaA.E. LauberC. Taxonomy of Viruses; Biomedical sciences.Elsevier2019117
    [Google Scholar]
  3. WuA. PengY. HuangB. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China.Cell Host Microbe202027332532810.1016/j.chom.2020.02.001 32035028
    [Google Scholar]
  4. FanY. ZhaoK. ShiZ.L. ZhouP. Bat coronaviruses in China.Viruses201911321010.3390/v11030210 30832341
    [Google Scholar]
  5. CherryJ. Demmler HarrisonG.J. KaplanS.L. SteinbachW.J. HotezP.J. Coronavirus-19, feigin and cherry’s textbook of pediatric infectious diseases.Elsevier health sciences20176615
    [Google Scholar]
  6. WooP.C.Y. HuangY. LauS.K.P. YuenK.Y. Coronavirus genomics and bioinformatics analysis.Viruses2010281804182010.3390/v2081803 21994708
    [Google Scholar]
  7. WuC. LiuY. YangY. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.Acta Pharm. Sin. B202010576678810.1016/j.apsb.2020.02.008 32292689
    [Google Scholar]
  8. Symptoms of COVID-19.Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
  9. KreyeJ. ReinckeS.M. KornauH.C. Sanchez-SendinE. CormanV.M. LiuH. A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model.bioRxiv20202020
    [Google Scholar]
  10. MilletJ.K. WhittakerG.R. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein.Proc. Natl. Acad. Sci. USA201411142152141521910.1073/pnas.1407087111 25288733
    [Google Scholar]
  11. KubaK. ImaiY. Ohto-NakanishiT. PenningerJ.M. Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters.Pharmacol. Ther.2010128111912810.1016/j.pharmthera.2010.06.003 20599443
    [Google Scholar]
  12. ChockalingamA.K. HamedS. GoodwinD.G. The effect of oseltamivir on the disease progression of lethal influenza A virus infection: Plasma cytokine and miRNA responses in a mouse model.Dis. Markers2016201611210.1155/2016/9296457 27110056
    [Google Scholar]
  13. FeretB.M. Handbook of Nonprescription Drugs.American Pharmacists Association2015
    [Google Scholar]
  14. AfridiM.I. RasoolG. TabassumR. ShaheenM. Siddiqullah, Shujauddin M. Prevalence and pattern of self-medication in Karachi: A community survey.Pak. J. Med. Sci.20153151241124510.12669/pjms.315.8216 26649022
    [Google Scholar]
  15. FoxE.R. StolbachA.I. Mazer-AmirshahiM. The landscape of prescription drug shortages during the COVID-19 pandemic.J. Med. Toxicol.202016331131310.1007/s13181‑020‑00786‑4 32458230
    [Google Scholar]
  16. Title of subordinate document.Available from: https://www.ashp.org/Drug-Shortages/Current-Shortages/DrugShortages-List?page=CurrentShortages (Accessed February 2020).
  17. WuR. WangL. KuoH.C.D. An update on current therapeutic drugs treating COVID-19.Curr. Pharmacol. Rep.202063567010.1007/s40495‑020‑00216‑7 32395418
    [Google Scholar]
  18. ChanJ.F.W. LauS.K.P. ToK.K.W. ChengV.C.C. WooP.C.Y. YuenK.Y. Middle East respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease.Clin. Microbiol. Rev.201528246552210.1128/CMR.00102‑14 25810418
    [Google Scholar]
  19. CarterC. NotterJ. Pathophysiology of SARS-CoV-2 COVID-19: An Open Access Critical Care Textbook.Elsevier2021
    [Google Scholar]
  20. World Health Organization.Coronavirus disease (COVID-19): How is it transmitted.2021Available from https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-covid-19-how-is-it-transmitted
    [Google Scholar]
  21. YukselA. KaradoganD. Gunduz GurkanC. Unclear issues regarding COVID-19.Eurasian J. Med.202052219119610.5152/eurasianjmed.2020.20092 32612430
    [Google Scholar]
  22. World Health Organization. Advice for the public: Coronavirus disease (COVID-19).Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public
  23. World Health OrganizationRational use of personal protective equipment for coronavirus disease (COVID-19): Interim guidance.2019Available from https://www.who.int/publications/i/item/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages
    [Google Scholar]
  24. VelavanT.P. MeyerC.G. The COVID‐19 epidemic.Trop. Med. Int. Health202025327828010.1111/tmi.13383 32052514
    [Google Scholar]
  25. MarcoC. MichaelR. AleemA. DulebohnS.C. Di NapoliR. Features, Evaluation, and Treatment of Coronavirus (COVID-19).StatPearls2022
    [Google Scholar]
  26. MicheleE. Human rhinovirus/enterovirus in pediatric acute respiratory distress syndrome. J Pediatr Intensi Care202009020816
    [Google Scholar]
  27. JaberR.M. MafrachiB. Al-AniA. ShkaraM. Awareness and perception of COVID-19 among the general population: A Middle Eastern survey.PLoS One2021164e025046110.1371/journal.pone.0250461 33886655
    [Google Scholar]
  28. OtaniK. WatanabeT. HigashimoriA. A questionnaire-based survey on the impact of the COVID-19 pandemic on gastrointestinal endoscopy in Asia.Digestion2022103172110.1159/000520287 34758472
    [Google Scholar]
  29. JuX. ZhuY. WangY. A novel cell culture system modeling the SARS-CoV-2 life cycle.PLoS Pathog.2021173e100943910.1371/journal.ppat.1009439 33711082
    [Google Scholar]
  30. SinghP.K. AnvikarA. SinhaA. COVID-19 related knowledge, attitudes, and practices in Indian Population: An online national cross-sectional survey.PLoS One2022173e026475210.1371/journal.pone.0264752 35239718
    [Google Scholar]
  31. AucejoE.M. FrenchJ. Ugalde ArayaM.P. ZafarB. The impact of COVID-19 on student experiences and expectations: Evidence from a survey.J. Public Econ.2020191310427110.1016/j.jpubeco.2020.104271 32873994
    [Google Scholar]
  32. BiasioL.R. BonaccorsiG. LoriniC. PecorelliS. Assessing COVID-19 vaccine literacy: A preliminary online survey.Hum. Vaccin. Immunother.20211751304131210.1080/21645515.2020.1829315 33118868
    [Google Scholar]
  33. SinhaM PandeB SinhaR. Impact of COVID-19 lockdown on sleep-wake schedule and associated lifestyle related behavior: A national survey.J Public Health Res202093jphr.2020.1826.10.4081/jphr.2020.1826 32874967
    [Google Scholar]
  34. VarshneyM. ParelJ.T. RaizadaN. SarinS.K. Coronavirus-19, Initial psychological impact of COVID-19 and its correlates in Indian Community, An online survey.PLoS One2020155023387410.1371/journal.pone.0233874 32470088
    [Google Scholar]
  35. MitchellE.P. Corona Virus: Global pandemic causing world-wide shutdown.J. Natl. Med. Assoc.2020112211311410.1016/j.jnma.2020.03.015 32253007
    [Google Scholar]
  36. ZhangC. YangL. LiuS. Survey of insomnia and related social psychological factors among medical staff involved with the 2019 novel coronavirus disease outbreak.Front. Psychiatry20201130610.3389/fpsyt.2020.00306 32346373
    [Google Scholar]
  37. KulkarniR. ChenW.C. LeeY. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.PLoS One2021169e025719110.1371/journal.pone.0257191 34499677
    [Google Scholar]
  38. MohamedN.A. SolehanH.M. Mohd RaniM.D. IthninM. Che IsahakC.I. Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey.PLoS One2021168e025611010.1371/journal.pone.0256110 34388202
    [Google Scholar]
  39. ZhuX.L. JiangH.H. JiangM.H. Questionnaire survey on the current situation and experience in prevention and control measures at urology clinics during the COVID-19 epidemic in China.Front. Public Health2021967088910.3389/fpubh.2021.670889 34490178
    [Google Scholar]
  40. HochheimerC.J. SaboR.T. KristA.H. DayT. CyrusJ. WoolfS.H. Methods for evaluating respondent attrition in web-based surveys.J. Med. Internet Res.20161811e30110.2196/jmir.6342 27876687
    [Google Scholar]
  41. One-Sample Kolmogorov-Smirnov Test.Available from: https://www.ibm.com/docs/en/spss-statistics/25.0.0?topic=tests-one-sample-kolmogorov-smirnov-test
  42. SilveiraD. Prieto-GarciaJ.M. BoylanF. COVID-19: Is there evidence for the use of herbal medicines as adjuvant symptomatic therapy?Front. Pharmacol.20201158184010.3389/fphar.2020.581840 33071794
    [Google Scholar]
  43. WagnerL. CramerH. KloseP. Herbal medicine for cough: A systematic review and meta-analysis.Complement. Med. Res.201522635936810.1159/000442111 26840418
    [Google Scholar]
  44. AngL. SongE. LeeH.W. LeeM.S. Herbal medicine for the treatment of Coronavirus Disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials.J. Clin. Med.202095158310.3390/jcm9051583 32456123
    [Google Scholar]
  45. SultanaJ. CutroneoP.M. CrisafulliS. PuglisiG. CaramoriG. TrifiròG. Azithromycin in COVID-19 patients: Pharmacological mechanism, clinical evidence and prescribing guidelines.Drug Saf.202043869169810.1007/s40264‑020‑00976‑7 32696429
    [Google Scholar]
  46. NoorA.U.Z. KabirH. ChowdhuryM.A.A. AtherM.F. Kamrul HasanM. An emerging route to antibiotic resistance in South Asia: A correspondence.Ann. Med. Surg.202385233533610.1097/MS9.0000000000000165 36845780
    [Google Scholar]
/content/journals/covid/10.2174/0126667975282230240125113214
Loading
/content/journals/covid/10.2174/0126667975282230240125113214
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test